Our blogs explain health conditions and clinical research in a way that is easy to follow, so readers can feel more informed
How Embedded Clinical Research Improves Trial Data Quality and Enrollment
When a clinical trial fails to enroll on time, the problem rarely starts with recruitment. It starts with the distance between where patients receive care and where research happens. Traditional site models ask patients to travel to separate facilities, follow separate...
How to Fix Patient Recruitment Bottlenecks in Trials
Few problems cost sponsors more time and money than patient recruitment bottlenecks in Phase II and III trials. A study that cannot enroll on schedule delays first patient in, pushes back database lock, and threatens the entire development timeline. For clinical...
Why Diverse Patient Recruitment Matters in Trials
Recruitment and retention remain the two hardest problems in clinical research, and they are getting harder. For pharmaceutical sponsors and CRO clinical operations leaders running Phase II and III studies, weak clinical trial patient recruitment delays timelines, inflates costs, and produces...
Where Oncology Trials Stall: 7 Partners That Get Sites Live Faster
In oncology, the gap between a signed contract and a fully activated site is where timelines quietly slip away. For pharmaceutical sponsors, CRO leaders, and biotech clinical operations teams running Phase II and III cancer studies, oncology site activation is one...
Top Oncology Clinical Trial Site Partners for Biotechs
Choosing the right oncology clinical trial site can determine whether a study enrolls on time, retains patients, and produces clean data that holds up to regulatory scrutiny. For pharmaceutical sponsors and biotech clinical operations leaders, the decision goes far beyond geography....
Clinical Trial Patient Recruitment in Phase II and III
Phase II and III trials are where sponsors commit the most time, capital, and scientific reputation, yet they are also where participant loss does the most damage. A study that enrolls slowly or bleeds participants midway through dosing can push timelines...
Improve Patient Retention in Phase II III Trials
Retention is where many Phase II and III studies quietly lose ground, and it almost always traces back to how the study began. Strong patient retention in clinical trials depends less on chasing dropouts and more on building continuity from the...
What Embedded Research Means for Clinical Trials
The way sponsors design enrollment is shifting, and embedded research in clinical trials sits at the center of that change. Rather than asking patients to travel to dedicated research facilities, this approach folds studies into the everyday practices where people already...
How Recruitment Models Are Reshaping Biotech Trial Enrollment
Biotech trial recruitment has become the deciding factor in whether a study finishes on time or stalls in startup. For sponsors and clinical operations leaders, the question is no longer whether to outsource recruitment but which model actually reaches the patients...
How Clinical Trial Data Quality Improves Across Phase I, II, and III
Clinical trial data quality is essential to every successful clinical study. Accurate, timely, and inspection-ready information allows sponsors and CROs to evaluate safety, study performance, and clinical outcomes with confidence. However, clinical trial data quality does not result from a single...
How Embedded Research Models Improve Trial Enrollment
Clinical trial enrollment remains one of the most persistent challenges in medical research. Sponsors and CROs may identify promising study locations, launch recruitment campaigns, and invest in outreach programs, yet many studies still struggle to connect with qualified participants. One reason...
Language Barriers in Clinical Trial Recruitment
Language differences are among the most persistent patient recruitment challenges in community-based clinical research. Potential participants must understand why a study is being conducted, what participation involves, how often they will need to attend visits, and what will happen during the...